Self-seeding in cancer

Recent Results in Cancer Research

Volumn 195, Issue , 2012, Pages 13-23

  Comen, Elizabeth ^a   Norton, Larry ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CANCER RISK; CIRCULATING TUMOR CELL; DRUG DESIGN; ECHOMAMMOGRAPHY; GENETIC ASSOCIATION; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MATHEMATICAL MODEL; PRIORITY JOURNAL; RISK FACTOR; TUMOR BIOPSY; TUMOR SEEDING; TUMOR VOLUME;

HUMANS; MODELS, THEORETICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84860580541     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-28160-0_2     Document Type: Article

References (48)

1. Norton L, Massague J (2006) Is cancer a disease of self-seeding? Nat Med 12(8):875-878
2. Kim MY et al (2009) Tumor self-seeding by circulating cancer cells. Cell 139(7):1315-1326
3. Uhr JW, Pantel K (2011) Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A 108(30):12396-400
4. LaBarge MA, Petersen OW, Bissell MJ (2007) Of microenvironments and mammary stem cells. Stem Cell Rev 3(2):137-146 (Pubitemid 350129716)
5. Minn AJ et al (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A 104(16):6740-6745 (Pubitemid 47175571)
6. Bos PD et al (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459(7249):1005-1009
7. Lu X et al (2009) ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 23(16):1882-1894
8. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9(4):274-284
9. Cenkowski M et al (2011) Tumor-to-tumor metastasis: report of a case of renal cell carcinoma metastasizing to a pancreatic endocrine neoplasm. J clin oncol off j Am Soc Clin Oncol 29(11):e303-e304
10. Norton L (2008) Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. Breast Dis 29:27-36
11. Norton L, Simon R (1977) Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep 61(7):1307-1317 (Pubitemid 8204100)
12. GompertzB(1832)On the nature of the function expressive of the lawof humanmortality, and on a newmode of determining the value of life contingencies. Phil TransRoy SocLondon 123:513-585
13. Norton L (1988)AGompertzian model of human breast cancer growth. Cancer Res 48(24 Pt 1): 7067-7071 (Pubitemid 19013983)
14. Halsted W (1907) The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46(1):1-19
15. Irving A (1979) Results of treating 1,178 patients with breast cancer by radical mastectomy and postoperative irradiation where metastases to axillary lymph nodes occurred. J Surg Oncol 12:137-153
16. Schoppmann SF et al (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240(2):306-312 (Pubitemid 38963023)
17. Cox C et al (2006) Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 13(5):708-711
18. Lyman GH et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703-7720 (Pubitemid 46291835)
19. Clarke M et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087-2106 (Pubitemid 41797643)
20. Shapiro DM, Fugmann RA (1957) A role for chemotherapy as an adjunct to surgery. Cancer Res 17(11):1098-1101
21. Fisher B (1977) Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 40(1 suppl):574-587 (Pubitemid 8175484)
22. Andersson Y et al (2010) Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 28(17):2868-2873
23. Giuliano AE et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6): 569-575
24. Wo JY et al (2011) Effect of very small tumor size on cancer-specific mortality in nodepositive breast cancer. J Clin Oncol
25. Hernandez-Aya LF et al (2011) Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. J Clin Oncol
26. Zhang XH et al (2009) Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16(1):67-78
27. Whelan TJ, Olivotto I, Ackerman I, Chapman JW, Chua B, NabidA, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Craighead P, Nolan MC, Bowen J, McCready DR, Pritchard KI, Levine MN, Parulekar W (2011) NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 29
28. Recht A et al (1996) The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334(21):1356-1361 (Pubitemid 26152714)
29. Richardson WW, Bloom HJG (1957) Histological grading and prognosis in breast cancer a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3):359-377
30. Group ECO (2011) A Randomized Phase III Trial of the value of early local therapy for the intact primary tumor in patients with metastatic breast cancer E2108, 23 June 2011
31. Neuman HB et al (2010) Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer 116(5):1226-1233
32. Bafford AC et al (2009) Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat 115(1):7-12
33. Bombonati A, Sgroi DC (2011) The molecular pathology of breast cancer progression. J Pathol 223(2):307-317
34. Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, Rimner A, Chan TA, Comen E, Andrade VP, Kim SW, King TA, Hudis CA, Norton L, Hicks J, Massagué J, Tavazoie SF (2011) MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25(3):226-231
35. Moelans CB et al (2010) Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Anal Cell Pathol (Amst) 33(3):165-173
36. Liu H et al (2010) Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A 107(42):18115-18120
37. Wicha MS, Liu S, Dontu G (1883) Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66(4):1883-1890 (discussion 1895-1896)
38. Paik S et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, nodenegative breast cancer. N Engl J Med 351(27):2817-2826 (Pubitemid 40051905)
39. van de Vijver MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999-2009 (Pubitemid 35461656)
40. Sotiriou C, Pusztai L (2009) Gene-expression signatures in breast cancer. N Engl J Med 360(8):790-800
41. Alowami S et al (2003) Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 5(5):R129-R135
42. Boyd NF et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886-894
43. Radisky DC, Hartmann LC (2009) Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 14(2):181-191
44. Ghosh K et al (2010) Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst 102(22):1716-1723
45. Provenzano PP et al (2008) Collagen density promotes mammary tumor initiation and progression. BMC Med 6:11
46. Criscitiello C, Sotiriou C, Ignatiadis M (2010) Circulating tumor cells and emerging blood biomarkers in breast cancer. Curr Opin Oncol 22(6):552-558
47. Jones RG, Thompson CB (2009) Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 23(5):537-548
48. Peggs KS et al (2006) Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr Opin Immunol 18(2):206-213 (Pubitemid 43327304)